Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

After-Hours Stock Movers: Oxford, Nikola Higher; Traeger, KB Home Lower

Published 03/23/2022, 05:52 PM
Updated 03/23/2022, 05:54 PM

After-Hours Stock Movers:

Traeger Inc (NYSE:COOK) 15.5% LOWER; reported Q4 EPS of $0.03, $0.08 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $174.9 million versus the consensus estimate of $158.54 million. Traeger, Inc. sees FY2022 revenue of $800-850 million, versus the consensus of $955 million.

Ra Medical Systems (NYSE:RMED) 11.8% LOWER; reported Q4 EPS of ($1.23), $0.38 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $5 thousand versus the consensus estimate of $350 thousand.

Oxford Industries (NYSE:OXM) 8.3% HIGHER; reported Q3 EPS of $1.50, $0.07 better than the analyst estimate of $1.43. Revenue for the quarter came in at $299.9 million versus the consensus estimate of $294.63 million. Oxford Industries sees FY2021 EPS of $8.75-$9.15, versus the consensus of $7.75. Oxford Industries sees FY2021 revenue of $1.245-1.285 billion, versus the consensus of $1.14 billion.

Apellis Pharmaceuticals, Inc., (NASDAQ:APLS) 7.1% LOWER; commenced an underwritten public offering of $300 million of its common stock.

H B Fuller Company (NYSE:FUL) 5.3% HIGHER; reported Q1 EPS of $0.80, $0.07 better than the analyst estimate of $0.73. Revenue for the quarter came in at $857 million versus the consensus estimate of $817.14 million. H.B. Fuller sees FY2022 EPS of $4.10-$4.35, versus the consensus of $4.16.

Relmada Therapeutics (NASDAQ:RLMD) 5% HIGHER; reported Q4 EPS of ($1.80), $0.03 better than the analyst estimate of ($1.83).

Nikola Corp (NASDAQ:NKLA) 4.5% HIGHER; Says Commercial Truck Production Started This Week - Bloomberg

KB Home (NYSE:KBH) 4.5% LOWER; reported Q1 EPS of $1.47, $0.09 worse than the analyst estimate of $1.56. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.5 billion. Sees FY housing revenues in the range of $7.20 billion to $7.60 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Ascendis Pharma A/S (Nasdaq: NASDAQ:ASND) 4.4% LOWER; to offer, subject to market and other conditions, US$500,000,000 aggregate principal amount of convertible senior notes due 2028 (the notes) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Steelcase (NYSE:SCS) 4.2% LOWER; reported Q4 EPS of ($0.02), $0.02 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $753.1 million versus the consensus estimate of $752.7 million. Steelcase sees Q1 2023 revenue of $680-705 million, versus the consensus of $689.5 million.

Infinera Corp . (NASDAQ:INFN) 3.4% HIGHER; with a Buy rating and a price target of $12.00.

Spotify (NYSE:SPOT) 3.1% HIGHER; entered into a multi-year agreement with Alphabet Inc. (Nasdaq: NASDAQ:GOOGL) to provide its customers an option to pay with either Spotify's payment system or with Google Play Billing when downloading Spotify from the Google Play Store.

Wix.com Ltd. (Nasdaq: NASDAQ:WIX) 1.8% HIGHER; announced that its Board of Directors had authorized a $500 million securities repurchase program.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.